Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add filters








Year range
1.
Journal of Paramedical Sciences. 2016; 7 (2): 1-7
in English | IMEMR | ID: emr-186136

ABSTRACT

Myelin basic protein [MBP] is one of the most important constituents of the CNS myelin sheaths. It is supposed that an autoimmune response directed against MBP is crucial in the demyelination process in patients with multiple sclerosis. Studies have proved that free anti-MBP level in CSF of MS patients is declined when the patient entered into clinical remission. Some researchers evaluate the changes in serum or CSF level of this antibody during immunomodulatory therapy; the results are different and the relation between the changes in this antibody and response to treatment is poorly investigated


The objective of this study was to assess the relation between the changes in serum level of anti-MBP and clinical remission in patients during treatment with fingolimod. 37 MS patients that were non responder to interferon and glatiramer acetate and were candidates to receive fingolimod were nominated for this study. In this study, the serum level of anti-MBP was evaluated before and after 3 and 6 months of therapy and clinical remission was assessed by changes in Expanded Disability Status Scale [EDSS] scores


The result of this study showed that MS patients, after treatment with interferon, have lower serum anti-MBP level than healthy control group and this difference is statistically significant [p =0.03]


The present study demonstrated that the serum anti-MBP level in MS patient during 6 months of treatment with fingolimod significantly decreased [p<0.001]. However, there was no significant difference in EDSS of MS patients during 6 months of treatment with fingolimod [p < 0.001]

2.
Journal of Research on History of Medicine [The]. 2015; 4 (1): 9-12
in English | IMEMR | ID: emr-181670
3.
Journal of Research on History of Medicine [The]. 2015; 4 (3): 133-134
in English | IMEMR | ID: emr-181682
4.
Iranian Journal of Public Health. 2014; 43 (8): 1157-1158
in English | IMEMR | ID: emr-152991
5.
Iranian Journal of Public Health. 2014; 43 (6): 855-856
in English | IMEMR | ID: emr-167608

Subject(s)
History of Medicine
6.
Iranian Journal of Public Health. 2014; 43 (11): 1550-1556
in English | IMEMR | ID: emr-167641

ABSTRACT

Multiple sclerosis [MS] is an autoimmune disease that affects physical and emotional aspects of patient's lives. The aim of this study was to evaluate Emotional Intelligence [EI] in cases with MS. One hundred sixty six clinically definite MS and 110 healthy subjects were enrolled in this study. All participants filled valid and reliable Persian version Emotional Quotient inventory [EQ-i] questionnaire, which had been developed due to Bar-On model. Mean EI total score and 12 out of 15 subscales were significantly different between patients and controls. Total EI score and most of its subscales were significantly higher in patients with RR [Relapsing Remitting] than Secondary Progressive [SP] ones. There was significant negative correlation between EDSS and total EI score [rho=-0.4, P<0.001]. Multiple linear regression analysis between the EI as a dependent variable and sex, type of disease, level of education, age and marital status as independent variables in patients showed that type of disease and level of education were independent predictors of EI. Emotional intelligence as the ability to behave better and communicate with others should be considered in MS cases as their physical and psychological health are affected by their illness


Subject(s)
Humans , Male , Female , Multiple Sclerosis , Surveys and Questionnaires , Cross-Sectional Studies
7.
Iranian Journal of Public Health. 2014; 43 (11): 1595-1596
in English | IMEMR | ID: emr-167652

Subject(s)
Vision, Ocular
8.
Journal of Research on History of Medicine [The]. 2014; 3 (3): 181-182
in English | IMEMR | ID: emr-181660
9.
Journal of Research on History of Medicine [The]. 2014; 3 (4): 191-194
in English | IMEMR | ID: emr-181662
10.
Tehran University Medical Journal [TUMJ]. 2012; 70 (7): 430-435
in Persian | IMEMR | ID: emr-160531

ABSTRACT

Finding an acute brain lesion by diffusion-weighted [DW] MRI upon an episode of transient ischemic attack [TIA] is a predictor of imminent stroke in the near future. Therefore, exploring risk factors associated with lesions in DW-MRI of the brain is important in adopting an approach to TIA management. In the current study, we tried to determine the risk factors associated with lesions in DW-MRI of the brain in patients experiencing TIA episodes. Fifty patients with TIA were recruited consecutively in Sina Hospital, Tehran, Iran, over a 6-month period between July 2008 and January 2009. All of the patients underwent a complete neurological examination and laboratory tests. Brain DW-MRIs were performed for all the patients within 72 hours of a TIA episode. DW-MRI revealed an acute lesion in 16% of the participants. There was a significant correlation between presence of an acute lesion in DW-MRI and TIA duration, history of diabetes mellitus and presence of unilateral facial palsy [P=0.0003, P=0.02 and P=0.008, respectively]. Other variables such as age, hypertension, hyperlipidemia, past history of TIA, headache, vertigo, and sensory or visual disturbances had no significant relation with the presence of an acute lesion in DW-MRI. Duration of TIA, presence of diabetes mellitus and unilateral facial palsy are risk factors for an acute lesion in DW-MRI, meaning that patients with such risk factors are at risk for stroke in the near future

SELECTION OF CITATIONS
SEARCH DETAIL